PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31579410-10	2019	Furthermore, levels of p-DVL-2Ser143 and major Wnt-signaling proteins decreased significantly after treatment of A549/DDP cells with CX4945+cisplatin, whereas DVL-2 and p-DVL-2Thr224 levels remained unchanged.	Cisplatin	140-149	dishevelled segment polarity protein 2	Homo sapiens	25-30	
27432651-4	2016	Here, we found that DVL2 was over-expressed in cisplatin-resistant human lung cancer cells A549/CDDP compared to the parental A549 cells.	Cisplatin	47-56	dishevelled segment polarity protein 2	Homo sapiens	20-24	
27432651-4	2016	Here, we found that DVL2 was over-expressed in cisplatin-resistant human lung cancer cells A549/CDDP compared to the parental A549 cells.	Cisplatin	96-100	dishevelled segment polarity protein 2	Homo sapiens	20-24	
27432651-5	2016	Inhibition of DVL2 by its inhibitor (3289-8625) or shDVL2 resensitized A549/CDDP cells to cisplatin.	Cisplatin	90-99	dishevelled segment polarity protein 2	Homo sapiens	14-18	
27432651-9	2016	Taken together, these results suggested that inhibition of DVL2 can sensitize cisplatin-resistant lung cancer cells through down-regulating Wnt/beta-catenin signaling and inhibiting BCRP, MRP4, and Survivin expression.	Cisplatin	78-87	dishevelled segment polarity protein 2	Homo sapiens	59-63